Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy

  • Makoto Ito
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Takeshi Kodaira
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Hiroyuki Tachibana
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Natsuo Tomita
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Chiyoko Makita
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Yutaro Koide
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Daiki Kato
    Department of Radiation Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Tetsuya Abe
    Department of Gastroenterological Surgery Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Kei Muro
    Department of Clinical Oncology Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Masahiro Tajika
    Department of Endoscopy Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Yasumasa Niwa
    Department of Endoscopy Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan
  • Yasuhisa Hasegawa
    Department of Head and Neck Surgery Aichi Cancer Center Hospital Chikusa‐ku Nagoya Japan

抄録

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The efficacy of intensity‐modulated radiotherapy (IMRT) for cervical esophageal cancer has not been determined.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Eighty patients with cervical esophageal cancer treated with definitive chemoradiotherapy from 2002 to 2014 were analyzed. Overall survival (OS), failure patterns, and toxicity incidence were compared between the IMRT (N = 32) and 3D conformal radiotherapy (RT; N = 48) groups.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The median follow‐up was 35.9 months. The 3‐year OS of the IMRT, 3D conformal RT, and total groups was 81.6%, 57.2%, and 66.6%, respectively. Pulmonary toxicity was not observed with IMRT. Six of 62 cases (9.6%) with nodal involvement developed upper cervical node recurrence outside the prophylactic region. Ten patients in the IMRT group were salvaged, and 60% survived without recurrence; 20% of the 3D conformal RT group was salvaged.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The IMRT group was comparable with 3D conformal RT group, with a better salvage rate. We recommend extended cervical irradiation for nodal involvement.</jats:p></jats:sec>

収録刊行物

  • Head & Neck

    Head & Neck 39 (12), 2406-2415, 2017-09-27

    Wiley

被引用文献 (3)*注記

もっと見る

参考文献 (24)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ